Patent details
300293 Product Name: Fesoterodine, desgewenst in de vorm van een farmaceutisch aanvaardbaar zuuradditie zout, in het bijzonder fumaraat
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300293
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP1077912
- Status:
- Expired Art. 14 (a) of the EC Regulations
- Application number:
- 300293
- Procedural language:
- Dutch
- First Applicant Residence Country:
Marketing Authorization
- Marketing Authorization Number:
- EU/1/07/386/001-010
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 24/04/2007
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 13/09/2007
- First Marketing Authorization date:
- 24/04/2007
- Grant date:
- 22/01/2008
- Activation date:
- 11/05/2019
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 13/09/2007
- SPC/SPC Extension Expiration Date:
- 23/04/2022
- Lapsed By Expiration Date:
- 24/04/2022
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 28/09/2017
- Name:
- UCB Pharma GmbH
- Address:
- Alfred-Nobel-Strasse 10, D-40789, Monheim, Germany (DE)
Historical Applicant/holder
- From:
- 13/09/2007
- To:
- 28/09/2017
- Name:
- SCHWARZ PHARMA AG
- Address:
- Alfred-Nobel-Strasse 10, D-40789, Monheim, Germany (DE)
Agent
- Name:
- ir. M.F.J.M. Ketelaars c.s.
- From:
- 13/09/2007
- Address:
- NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
- To:
Licensee
- Name:
- Pfizer lnc.
- From:
- 28/09/2017
- Address:
- 235 East 42nd Street, 10017, New York, NY, United States of America (US)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 17/22
- Publication date:
- 29/04/2022
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- SPC
- Journal edition number:
- 20/19
- Publication date:
- 15/05/2019
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
- Bulletin Heading:
- CO
- Journal edition number:
- 45/17
- Publication date:
- 08/11/2017
- Description:
- Changes in the Netherlands Patent Register
4
- Bulletin Heading:
- MED
- Journal edition number:
- 45/17
- Publication date:
- 08/11/2017
- Description:
- Other communications
5
- Bulletin Heading:
- SPC
- Journal edition number:
- 2008/03
- Publication date:
- 03/03/2008
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
6
- Bulletin Heading:
- SPC
- Journal edition number:
- 2007/11
- Publication date:
- 01/11/2007
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name
- Deed Number:
- RC201701930A
- Date Registered:
- 28/09/2017
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. M.F.J.M. Ketelaars c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- UCB Pharma GmbH
- Address:
- Alfred-Nobel-Strasse 10, D-40789, Monheim, Germany (DE)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Licence
- Change Kind/ Decision Type:
- New licence registration
- Deed Number:
- RC201701930B
- Date Registered:
- 28/09/2017
- License Effective Date:
- 28/09/2017
- License Expiration Date:
- Scope of License:
- Exclusive
- Deed Filer:
- ir. M.F.J.M. Ketelaars c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Licensee(s)
- Name:
- Pfizer lnc.
- Address:
- 235 East 42nd Street, 10017, New York, NY, United States of America (US)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 22/03/2021
- Last Annual Fee Paid Number:
- 23
- Last Annual Fee Paid Amount:
- 2000 Euro
- Payer:
- Master Data Center
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 05/01/2016 | Outgoing Correspondence | Decision grant | 1 | /3/9/2/0/0/0400300293/docs/300293_5_outgoingcorrespondence20210216030924567.pdf | ||
| 05/01/2016 | SPC Documents | Certificate SPC | 1 | /3/9/2/0/0/0400300293/docs/300293_7_supplprotectioncertificate20210216031030153.pdf | ||
| 12/11/2015 | Incoming Correspondence Paper | Accompanying letter incoming document | 2 | /3/9/2/0/0/0400300293/docs/300293_8_incomingcorrespondencepaper20151209111634404.pdf | ||
| 12/11/2015 | SPC Documents | Annex SPC | 1 | /3/9/2/0/0/0400300293/docs/300293_11_supplprotectioncertificate20210216030635353.pdf | ||
| 22/01/2008 | SPC Documents | Certificate SPC | 1 | /3/9/2/0/0/0400300293/docs/300293_0_supplprotectioncertificate20210216030305540.pdf | ||
| 22/01/2008 | Outgoing Correspondence | Outgoing Letter | 1 | /3/9/2/0/0/0400300293/docs/300293_1_outgoingcorrespondence20080122.pdf | ||
| 18/12/2007 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /3/9/2/0/0/0400300293/docs/300293_14_incomingcorrespondencepaper20080121.pdf | ||
| 01/11/2007 | Outgoing Correspondence | Outgoing Letter | 2 | /3/9/2/0/0/0400300293/docs/300293_4_outgoingcorrespondence20071101.pdf | ||
| 03/10/2007 | SPC Documents | Annex SPC | 4 | /3/9/2/0/0/0400300293/docs/300293_6_supplprotectioncertificate20210216025847552.pdf | ||
| 03/10/2007 | SPC Documents | Annex SPC | 90 | /3/9/2/0/0/0400300293/docs/300293_10_supplprotectioncertificate20210216030010656.pdf | ||
| 03/10/2007 | SPC Documents | Annex SPC | 1 | /3/9/2/0/0/0400300293/docs/300293_12_supplprotectioncertificate20210216025755976.pdf | ||
| 14/09/2007 | Outgoing Correspondence | Outgoing Letter | 1 | /3/9/2/0/0/0400300293/docs/300293_13_outgoingcorrespondence20070914.pdf | ||
| 13/09/2007 | Application Form | First filed application form | 2 | /3/9/2/0/0/0400300293/docs/300293_2_applicationform20070913.pdf | ||
| 13/09/2007 | SPC Documents | Marketing Authorization SPC | 4 | /3/9/2/0/0/0400300293/docs/300293_3_supplprotectioncertificate20210216025614548.pdf | ||
| 13/09/2007 | SPC Documents | Summary of the characteristics of the product | 21 | /3/9/2/0/0/0400300293/docs/300293_9_supplprotectioncertificate20210216025451823.pdf |